Price T Rowe Associates Inc Chroma Dex Corp. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 39,300 shares of CDXC stock, worth $98,642. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,300
Previous 39,300
-0.0%
Holding current value
$98,642
Previous $57,000
140.35%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CDXC
# of Institutions
71Shares Held
13.1MCall Options Held
97.1KPut Options Held
17.6K-
Vanguard Group Inc Valley Forge, PA3.05MShares$7.65 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA3.02MShares$7.58 Million5.51% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$3.25 Million0.08% of portfolio
-
Black Rock Inc. New York, NY903KShares$2.27 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny584KShares$1.47 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $172M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...